Format

Send to

Choose Destination
Lancet. 2017 Dec 16;390(10113):2625-2626. doi: 10.1016/S0140-6736(17)32138-4.

Targeted-release budesonide therapy for IgA nephropathy - Authors' reply.

Author information

1
Department of Medical Sciences, Renal Unit, Uppsala University Hospital, Uppsala, S-75185 Sweden. Electronic address: bengt.fellstrom@medsci.uu.se.
2
Department of Infection, Immunity and Inflammation, University of Leicester, Leicester, UK; John Walls Renal Unit, Leicester General Hospital, Leicester, UK; Postgraduate Specialty School of Clinical Academic Training, Health Education East Midlands, Leicester, UK.
3
Medizinische Klinik II, RWTH Aachen Univeristy, Aachen, Germany.
4
Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, Scotland; Glasgow Renal Transplant Unit, Queen Elizabeth Hospital, Glasgow, Scotland.
PMID:
29256402
DOI:
10.1016/S0140-6736(17)32138-4
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center